Edition:
United States

Elekta AB (publ) (EKTAb.ST)

EKTAb.ST on Stockholm Stock Exchange

67.90SEK
15 Dec 2017
Change (% chg)

-1.10kr (-1.59%)
Prev Close
69.00kr
Open
69.00kr
Day's High
69.00kr
Day's Low
67.20kr
Volume
2,860,962
Avg. Vol
1,443,359
52-wk High
95.90kr
52-wk Low
66.90kr

Chart for

About

Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer... (more)

Overall

Beta: 0.96
Market Cap(Mil.): kr25,432.55
Shares Outstanding(Mil.): 368.59
Dividend: 0.50
Yield (%): 1.45

Financials

  Industry Sector
P/E (TTM): -- 27.83 16.04
EPS (TTM): -- -- --
ROI: -- 10.01 35.70
ROE: -- 15.20 15.40

BRIEF-Elekta reaches agreement in dispute with Stockholm County Council

* ELEKTA AND STOCKHOLM COUNTY COUNCIL AGREE ON CONSTRUCTIVE WAY FORWARD

Dec 12 2017

UPDATE 1-Elekta delays order target for new radiation therapy machine

STOCKHOLM, Nov 30 Sweden's Elekta pushed back its order target for a new radiation therapy machine which is meant to drive its future sales growth on Thursday as it reported higher quarterly core earnings than expected.

Nov 30 2017

BRIEF-Elekta CEO: Unity radiation therapy system a 2018 sales driver

Nov 30 Elekta AB CEO Richard Hausmann and CFo Gustaf Salford in a conference call with analysts and media:

Nov 30 2017

Elekta postpones order target for new flagship product Unity

STOCKHOLM, Nov 30 Swedish radiotherapy gear maker Elekta on Thursday pushed back its target for order bookings of its new flagship radiation therapy machine Unity as it posted higher quarterly core earnings, but lower order intake, than expected.

Nov 30 2017

BRIEF-Elekta Q2 core profit beat expectations, orders lag

* SAYS ‍OUR TARGETS FOR YEAR ARE CLEAR - WE WILL DELIVER PROFITABLE GROWTH AND REACH AN EBITA MARGIN EXCEEDING 20 PERCENT THROUGH GROWTH AND OUR WORK WITH CONTINUOUS OPERATIONAL IMPROVEMENTS​

Nov 30 2017

BRIEF-Elekta signs £22 mln agrement with UK's National Health Service

* UK'S NATIONAL HEALTH SERVICE SIGNS GBP 22 MILLION AGREEMENT FOR ELEKTA CANCER TREATMENT SYSTEMS

Nov 29 2017

BRIEF-21St century oncology chooses Elekta for replacement of radiation therapy devices

* Elekta announces that 21st Century Oncology, the largest radiation oncology provider in the U.S., will replace several of its existing linear accelerators, as well as treatment planning software and oncology information systems, with advanced cancer treatment solutions from Elekta. Source text for Eikon: Further company coverage: (Reporting By Johan Ahlander)

Nov 21 2017

BRIEF-Elekta says CE mark for Unity is expected during first half of 2018

* Elekta has decided to add additional functional imaging capabilities to its MR-linac (Unity) and to spend more time on validating its linac control system

Nov 10 2017

BRIEF-Mclaren Health Care and Elekta mutually terminate long-term agreement

* Mclaren Health Care and Elekta have mutually agreed to terminate their long-term agreement.

Oct 11 2017

BRIEF- IBA and Elekta enter MOU regarding comprehensive partnership

* ANNOUNCED ON SATURDAY IBA AND ELEKTA ENTERED A MEMORANDUM OF UNDERSTANDING (MOU)REGARDING A COMPREHENSIVE PARTNERSHIP INCLUDING JOINT SOFTWARE DEVELOPMENT AND SALES TO ADVANCE PROTON THERAPY TREATMENTS Source text for Eikon:

Sep 25 2017

Earnings vs. Estimates